Manufacture of oils and fats
NORDIC PHARMA INC AS
Revenue 2024
NOK 288.8m
Operating profit
NOK 57.2m
Equity
NOK 330.2m
Incorporated
2005
Employees
52
Share capital
NOK 27.9m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 288.8m | |
| Total operating costs | 231.6m | |
| Operating profit (EBIT) | 57.2m | |
| Net financial items | −3.9m | |
| Profit for the year | 41.7m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 503.6m | |
| of which current assets | 220.9m | |
| Equity | 330.2m | |
| Total liabilities | 173.4m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.